Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity

Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity

Abstract Background Urinary 3-indoxyl sulfate levels as well as fecal short chain fatty acid (SCFA) concentrations are surrogate markers for gut microbiota diversity. Patients with inflammatory bowel diseases (IBDs) and patients with primary sclerosing cholangitis (PSC), a disease closely associated...

Full description

Bibliographic Details
Main Authors: Hauke Christian Tews, Tanja Elger, Stefan Gunawan, Tanja Fererberger, Stefanie Sommersberger, Johanna Loibl, Muriel Huss, Gerhard Liebisch, Martina Müller, Arne Kandulski, Christa Buechler
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Lipids in Health and Disease
Subjects:
Butyrate
Acetate
Calprotectin
Crohn´s disease
Ulcerative colitis
IBD
Online Access:https://doi.org/10.1186/s12944-023-01929-6

Internet

https://doi.org/10.1186/s12944-023-01929-6

Similar Items